Search Reports
Categories
Categories

Global Montelukast Api Market

Global Montelukast Api Market Research Report 2025(Status and Outlook)

Report Code : PHA2990
Published Date : 17 July, 1905 | No of Pages: 139

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Montelukast API (Active Pharmaceutical Ingredient) is a leukotriene receptor antagonist used in the treatment of asthma and allergic rhinitis by inhibiting the action of leukotrienes, which are inflammatory mediators involved in bronchoconstriction and airway inflammation. The market for Montelukast API is driven by the increasing global prevalence of respiratory diseases, particularly asthma and chronic obstructive pulmonary disease (COPD), coupled with rising awareness and diagnosis rates. Generic competition has intensified post-patent expiry, leading to price pressures but also expanding accessibility in emerging markets. Regulatory compliance, particularly adherence to Good Manufacturing Practices (GMP), remains a critical factor for suppliers, with key production hubs located in India and China. Demand is further supported by the growing preference for cost-effective generic alternatives in both developed and developing regions, though stringent quality controls and supply chain disruptions pose challenges. Strategic partnerships between API manufacturers and formulation companies are shaping the competitive landscape, while innovations in production efficiency and sustainability are gaining traction. The market is expected to grow steadily, supported by the persistent burden of respiratory conditions and the expansion of healthcare infrastructure in low- and middle-income countries.

This report offers a comprehensive and in-depth analysis of the global Montelukast Api market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Montelukast Api market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Montelukast Api market.
Global Montelukast Api Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Cipla
Morepen Laboratories
Sun Pharma
Teva Pharmaceutical Industries
Intas Pharmaceuticals
Apotex
Sanyo Chemical Industries
Mylan
Delmar Chemicals

Market Segmentation (by Type)
Tablet
Chewable Tablet
Oral Solution

Market Segmentation (by Application)
Asthma
Allergic Rhinitis
Urticaria
Bronchospasm
Others

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Montelukast Api Market
Overview of the regional outlook of the Montelukast Api Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Montelukast Api Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Montelukast Api, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Montelukast Api
      1.2 Key Market Segments
            1.2.1 Montelukast Api Segment by Type
            1.2.2 Montelukast Api Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Montelukast Api Market Overview
      2.1 Global Market Overview
            2.1.1 Global Montelukast Api Market Size (M USD) Estimates and Forecasts (2020-2033)
            2.1.2 Global Montelukast Api Sales Estimates and Forecasts (2020-2033)
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Montelukast Api Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Montelukast Api Product Life Cycle
      3.3 Global Montelukast Api Sales by Manufacturers (2020-2025)
      3.4 Global Montelukast Api Revenue Market Share by Manufacturers (2020-2025)
      3.5 Montelukast Api Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.6 Global Montelukast Api Average Price by Manufacturers (2020-2025)
      3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
      3.8 Montelukast Api Market Competitive Situation and Trends
            3.8.1 Montelukast Api Market Concentration Rate
            3.8.2 Global 5 and 10 Largest Montelukast Api Players Market Share by Revenue
            3.8.3 Mergers & Acquisitions, Expansion
  4 Montelukast Api Industry Chain Analysis
      4.1 Montelukast Api Industry Chain Analysis
      4.2 Market Overview of Key Raw Materials
      4.3 Midstream Market Analysis
      4.4 Downstream Customer Analysis
  5 The Development and Dynamics of Montelukast Api Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Montelukast Api Market Porter's Five Forces Analysis
            5.6.1 Global Trade Frictions
            5.6.2 U.S. Tariff Policy – April 2025
            5.6.3 Global Trade Frictions and Their Impacts to Montelukast Api Market
      5.7 ESG Ratings of Leading Companies
  6 Montelukast Api Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Montelukast Api Sales Market Share by Type (2020-2025)
      6.3 Global Montelukast Api Market Size Market Share by Type (2020-2025)
      6.4 Global Montelukast Api Price by Type (2020-2025)
  7 Montelukast Api Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Montelukast Api Market Sales by Application (2020-2025)
      7.3 Global Montelukast Api Market Size (M USD) by Application (2020-2025)
      7.4 Global Montelukast Api Sales Growth Rate by Application (2020-2025)
  8 Montelukast Api Market Sales by Region
      8.1 Global Montelukast Api Sales by Region
            8.1.1 Global Montelukast Api Sales by Region
            8.1.2 Global Montelukast Api Sales Market Share by Region
      8.2 Global Montelukast Api Market Size by Region
            8.2.1 Global Montelukast Api Market Size by Region
            8.2.2 Global Montelukast Api Market Size Market Share by Region
      8.3 North America
            8.3.1 North America Montelukast Api Sales by Country
            8.3.2 North America Montelukast Api Market Size by Country
            8.3.3 U.S. Market Overview
            8.3.4 Canada Market Overview
            8.3.5 Mexico Market Overview
      8.4 Europe
            8.4.1 Europe Montelukast Api Sales by Country
            8.4.2 Europe Montelukast Api Market Size by Country
            8.4.3 Germany Market Overview
            8.4.4 France Market Overview
            8.4.5 U.K. Market Overview
            8.4.6 Italy Market Overview
            8.4.7 Spain Market Overview
      8.5 Asia Pacific
            8.5.1 Asia Pacific Montelukast Api Sales by Region
            8.5.2 Asia Pacific Montelukast Api Market Size by Region
            8.5.3 China Market Overview
            8.5.4 Japan Market Overview
            8.5.5 South Korea Market Overview
            8.5.6 India Market Overview
            8.5.7 Southeast Asia Market Overview
      8.6 South America
            8.6.1 South America Montelukast Api Sales by Country
            8.6.2 South America Montelukast Api Market Size by Country
            8.6.3 Brazil Market Overview
            8.6.4 Argentina Market Overview
            8.6.5 Columbia Market Overview
      8.7 Middle East and Africa
            8.7.1 Middle East and Africa Montelukast Api Sales by Region
            8.7.2 Middle East and Africa Montelukast Api Market Size by Region
            8.7.3 Saudi Arabia Market Overview
            8.7.4 UAE Market Overview
            8.7.5 Egypt Market Overview
            8.7.6 Nigeria Market Overview
            8.7.7 South Africa Market Overview
  9 Montelukast Api Market Production by Region
      9.1 Global Production of Montelukast Api by Region(2020-2025)
      9.2 Global Montelukast Api Revenue Market Share by Region (2020-2025)
      9.3 Global Montelukast Api Production, Revenue, Price and Gross Margin (2020-2025)
      9.4 North America Montelukast Api Production
            9.4.1 North America Montelukast Api Production Growth Rate (2020-2025)
            9.4.2 North America Montelukast Api Production, Revenue, Price and Gross Margin (2020-2025)
      9.5 Europe Montelukast Api Production
            9.5.1 Europe Montelukast Api Production Growth Rate (2020-2025)
            9.5.2 Europe Montelukast Api Production, Revenue, Price and Gross Margin (2020-2025)
      9.6 Japan Montelukast Api Production (2020-2025)
            9.6.1 Japan Montelukast Api Production Growth Rate (2020-2025)
            9.6.2 Japan Montelukast Api Production, Revenue, Price and Gross Margin (2020-2025)
      9.7 China Montelukast Api Production (2020-2025)
            9.7.1 China Montelukast Api Production Growth Rate (2020-2025)
            9.7.2 China Montelukast Api Production, Revenue, Price and Gross Margin (2020-2025)
  10 Key Companies Profile
      10.1 Merck
            10.1.1 Merck Basic Information
            10.1.2 Merck Montelukast Api Product Overview
            10.1.3 Merck Montelukast Api Product Market Performance
            10.1.4 Merck Business Overview
            10.1.5 Merck SWOT Analysis
            10.1.6 Merck Recent Developments
      10.2 Cipla
            10.2.1 Cipla Basic Information
            10.2.2 Cipla Montelukast Api Product Overview
            10.2.3 Cipla Montelukast Api Product Market Performance
            10.2.4 Cipla Business Overview
            10.2.5 Cipla SWOT Analysis
            10.2.6 Cipla Recent Developments
      10.3 Morepen Laboratories
            10.3.1 Morepen Laboratories Basic Information
            10.3.2 Morepen Laboratories Montelukast Api Product Overview
            10.3.3 Morepen Laboratories Montelukast Api Product Market Performance
            10.3.4 Morepen Laboratories Business Overview
            10.3.5 Morepen Laboratories SWOT Analysis
            10.3.6 Morepen Laboratories Recent Developments
      10.4 Sun Pharma
            10.4.1 Sun Pharma Basic Information
            10.4.2 Sun Pharma Montelukast Api Product Overview
            10.4.3 Sun Pharma Montelukast Api Product Market Performance
            10.4.4 Sun Pharma Business Overview
            10.4.5 Sun Pharma Recent Developments
      10.5 Teva Pharmaceutical Industries
            10.5.1 Teva Pharmaceutical Industries Basic Information
            10.5.2 Teva Pharmaceutical Industries Montelukast Api Product Overview
            10.5.3 Teva Pharmaceutical Industries Montelukast Api Product Market Performance
            10.5.4 Teva Pharmaceutical Industries Business Overview
            10.5.5 Teva Pharmaceutical Industries Recent Developments
      10.6 Intas Pharmaceuticals
            10.6.1 Intas Pharmaceuticals Basic Information
            10.6.2 Intas Pharmaceuticals Montelukast Api Product Overview
            10.6.3 Intas Pharmaceuticals Montelukast Api Product Market Performance
            10.6.4 Intas Pharmaceuticals Business Overview
            10.6.5 Intas Pharmaceuticals Recent Developments
      10.7 Apotex
            10.7.1 Apotex Basic Information
            10.7.2 Apotex Montelukast Api Product Overview
            10.7.3 Apotex Montelukast Api Product Market Performance
            10.7.4 Apotex Business Overview
            10.7.5 Apotex Recent Developments
      10.8 Sanyo Chemical Industries
            10.8.1 Sanyo Chemical Industries Basic Information
            10.8.2 Sanyo Chemical Industries Montelukast Api Product Overview
            10.8.3 Sanyo Chemical Industries Montelukast Api Product Market Performance
            10.8.4 Sanyo Chemical Industries Business Overview
            10.8.5 Sanyo Chemical Industries Recent Developments
      10.9 Mylan
            10.9.1 Mylan Basic Information
            10.9.2 Mylan Montelukast Api Product Overview
            10.9.3 Mylan Montelukast Api Product Market Performance
            10.9.4 Mylan Business Overview
            10.9.5 Mylan Recent Developments
      10.10 Delmar Chemicals
            10.10.1 Delmar Chemicals Basic Information
            10.10.2 Delmar Chemicals Montelukast Api Product Overview
            10.10.3 Delmar Chemicals Montelukast Api Product Market Performance
            10.10.4 Delmar Chemicals Business Overview
            10.10.5 Delmar Chemicals Recent Developments
  11 Montelukast Api Market Forecast by Region
      11.1 Global Montelukast Api Market Size Forecast
      11.2 Global Montelukast Api Market Forecast by Region
            11.2.1 North America Market Size Forecast by Country
            11.2.2 Europe Montelukast Api Market Size Forecast by Country
            11.2.3 Asia Pacific Montelukast Api Market Size Forecast by Region
            11.2.4 South America Montelukast Api Market Size Forecast by Country
            11.2.5 Middle East and Africa Forecasted Sales of Montelukast Api by Country
  12 Forecast Market by Type and by Application (2026-2033)
      12.1 Global Montelukast Api Market Forecast by Type (2026-2033)
            12.1.1 Global Forecasted Sales of Montelukast Api by Type (2026-2033)
            12.1.2 Global Montelukast Api Market Size Forecast by Type (2026-2033)
            12.1.3 Global Forecasted Price of Montelukast Api by Type (2026-2033)
      12.2 Global Montelukast Api Market Forecast by Application (2026-2033)
            12.2.1 Global Montelukast Api Sales (K MT) Forecast by Application
            12.2.2 Global Montelukast Api Market Size (M USD) Forecast by Application (2026-2033)
  13 Conclusion and Key Findings
Merck
Cipla
Morepen Laboratories
Sun Pharma
Teva Pharmaceutical Industries
Intas Pharmaceuticals
Apotex
Sanyo Chemical Industries
Mylan
Delmar Chemicals
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400